These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1142 related items for PubMed ID: 27149857

  • 1. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP, Della Valle N, Rizzi S, Cleopazzo E, Centola A, Iamele D, Bristogiannis C, Stoppino G, Vinci R, Macarini L.
    BMC Med Imaging; 2016 May 05; 16(1):37. PubMed ID: 27149857
    [Abstract] [Full Text] [Related]

  • 2. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I, Rimola J, Rodríguez S, Paredes JM, Martínez-Pérez MJ, Blanc E, Arévalo JA, Aduna M, Andreu M, Radosevic A, Ramírez-Morros AM, Pinó S, Gallego M, Jauregui-Amezaga A, Ricart E, Panés J.
    Gastroenterology; 2014 Feb 05; 146(2):374-82.e1. PubMed ID: 24177375
    [Abstract] [Full Text] [Related]

  • 3. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Danese S, Sandborn WJ, Colombel JF, Vermeire S, Glover SC, Rimola J, Siegelman J, Jones S, Bornstein JD, Feagan BG.
    Gastroenterology; 2019 Oct 05; 157(4):1007-1018.e7. PubMed ID: 31279871
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies.
    Eder P, Stawczyk-Eder K, Korybalska K, Czepulis N, Luczak J, Lykowska-Szuber L, Krela-Kazmierczak I, Linke K, Witowski J.
    World J Gastroenterol; 2017 Jan 07; 23(1):135-140. PubMed ID: 28104989
    [Abstract] [Full Text] [Related]

  • 9. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG, Nieminen U, Sipponen T, Turunen U, Arkkila P, Färkkilä M.
    Scand J Gastroenterol; 2013 May 07; 48(5):543-51. PubMed ID: 23477356
    [Abstract] [Full Text] [Related]

  • 10. The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.
    Eder P, Katulska K, Krela-Kaźmierczak I, Stawczyk-Eder K, Klimczak K, Szymczak A, Linke K, Łykowska-Szuber L.
    Abdom Imaging; 2015 Oct 07; 40(7):2210-8. PubMed ID: 26048698
    [Abstract] [Full Text] [Related]

  • 11. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
    Peyrin-Biroulet L, Reinisch W, Colombel JF, Mantzaris GJ, Kornbluth A, Diamond R, Rutgeerts P, Tang LK, Cornillie FJ, Sandborn WJ.
    Gut; 2014 Jan 07; 63(1):88-95. PubMed ID: 23974954
    [Abstract] [Full Text] [Related]

  • 12. Baseline Wall Thickness Is Lower in Mucosa-Healed Segments 1 Year After Infliximab in Pediatric Crohn Disease Patients.
    Kang B, Choi SY, Chi S, Lim Y, Jeon TY, Choe YH.
    J Pediatr Gastroenterol Nutr; 2017 Feb 07; 64(2):279-285. PubMed ID: 27050057
    [Abstract] [Full Text] [Related]

  • 13. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
    Alfaro I, Masamunt MC, Planell N, López-García A, Castro J, Gallego M, Barastegui R, Giner A, Vara A, Salas A, Ricart E, Panés J, Ordás I.
    World J Gastroenterol; 2019 Apr 14; 25(14):1764-1774. PubMed ID: 31011260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease.
    Sagami S, Kobayashi T, Kikkawa N, Umeda S, Nakano M, Toyonaga T, Okabayashi S, Ozaki R, Hibi T.
    PLoS One; 2019 Apr 14; 14(2):e0212404. PubMed ID: 30785943
    [Abstract] [Full Text] [Related]

  • 18. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.
    Am J Gastroenterol; 2010 Jan 14; 105(1):162-9. PubMed ID: 19755969
    [Abstract] [Full Text] [Related]

  • 19. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B, Prka L.
    Acta Med Croatica; 2013 Apr 14; 67(2):179-89. PubMed ID: 24471301
    [Abstract] [Full Text] [Related]

  • 20. Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy.
    Messadeg L, Hordonneau C, Bouguen G, Goutorbe F, Reimund JM, Goutte M, Boucher AL, Scanzi J, Reymond M, Allimant C, Dapoigny M, Pereira B, Bommelaer G, Buisson A.
    J Crohns Colitis; 2020 Nov 07; 14(11):1524-1534. PubMed ID: 32533769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.